Cold Spring Harbor:A recent discovery by scientists at Cold Spring Harbor Laboratory (CSHL) highlights a protein that, while commonly associated with cancer growth, may also be pivotal in combating the disease. Researchers found that activating this protein in immune cells could enhance their ability to attack tumors, offering hope for developing new treatments for cancers that are resistant to current therapies.

According to Azerbaijan State News Agency, the study, published in Nature Immunology, could have significant implications for colorectal cancer, now the leading cause of cancer-related deaths among individuals under 50. Many patients with hard-to-treat cancer forms have limited treatment options, especially when conventional chemotherapy and newer immunotherapy approaches are ineffective. The research indicates that the protein, typically linked to cancer proliferation, could serve as a potent anti-cancer mechanism when activated in immune cells.

Central to this research is the protein called peroxisome proliferator-activated receptor delta (PPARD), which regulates how cells metabolize fat for energy. As a transcription factor, PPARD influences genes involved in critical cellular functions. The study conducted by CSHL Assistant Professor Semir Beyaz and his team involved mice with colorectal cancer, revealing that while cancer cells utilize PPARD for their benefit, activating it in immune cells instead supports the immune response against tumors.

Beyaz emphasizes the concept of "cell fitness," noting that the metabolic health and performance of cells directly affect their ability to combat cancer. By enhancing the fat-burning capacity of immune cells, they become more adept at fighting cancer. This insight into cellular fitness could pave the way for novel cancer treatment strategies.